Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Saving sight from diabetes complications

Saving sight from diabetes complications

Stories Feb 10, 2019 4 minutes

Cutting-edge imaging technique could result in earlier interventions and more resources for those most in need.

One of the most prevalent and concerning complications diabetes patients face is diabetic retinopathy (DR), which can lead to partial or complete vision loss. Now, a clinical trial based out of Vancouver Coastal Health Research Institute (VCHRI) could uncover clues about how the disease progresses, enabling clinicians to intervene quickly and only when necessary. 

“This research could lead to new non-invasive, non-harmful screening procedures that would tell us very early on which patients are at risk of developing severe sight-threatening diabetic retinopathy,” says Dr. Sonja Karst, a visiting scientist at the Vancouver General Hospital (VGH) Eye Care Centre. 

“Being able to differentiate between patients at high- and low-risk of developing sight-threatening DR would have huge advantages for patients and clinicians.”

Diabetes is a fairly common chronic disease where the body is either unable to produce insulin (Type 1) or properly use the insulin it produces (Type 2). It causes chronic high blood sugar levels, which can damage blood vessels, nerves and organs.

Within the first 20 years of the disease, DR affects almost all patients with Type 1 Diabetes and more than 60 per cent of patients with Type 2 Diabetes. This micro-vascular complication causes damage to the small blood vessels in the retina, the light-sensitive tissue located at the back of the eye. 

Dr. Sonja Karst is a specialist in diabetic retinopathy in the Department of Ophthalmology at the Medical University of Vienna in Austria. She is currently collaborating with VCHRI scientists at the Eye Care Centre in Vancouver.

In its early stages, DR might not cause any symptoms. However, advanced DR can lead to fluid accumulation or to the growth of abnormal blood vessels in the eye, which can cause blurred vision, dark spots and floaters. Abnormal blood vessels can develop and lead to vitreous hemorrhage, retinal detachment and sudden vision loss.

The risk of vision loss from DR-related eye diseases makes proper diagnosis and early treatment essential. 

The disease is more likely to progress to vision-threatening levels the longer someone lives with diabetes and when a patient’s blood sugar is not adequately controlled. The present challenge clinicians face is that it is still unclear who will and will not develop sight-threatening DR.  

Revolutionizing eye care for diabetic patients 

In collaboration with the VGH Diabetes Centre, Karst and VCHRI scientist Dr. David Maberley will employ a cutting-edge, non-invasive diagnostic test called optical coherence tomography angiography (OCTA) to evaluate patients who are at increased risk of DR worsening because of poor blood sugar control. 

OCTA uses a laser light to take high-resolution images of the tiny blood vessels of the eye’s retina. The scans reveal the vascular networks in the eye, as well as the thickness of patients’ retinas. Researchers will evaluate scans of patients’ eyes over a 12-month period, and will later use this data to better understand how DR develops and can worsen. 

The optical coherence tomography angiography (OCTA) machine can non-invasively take images of blood vessels in a patient’s eye within a matter of seconds. Research using this groundbreaking technology could uncover clues about the progression of DR among diabetic patients.

Unlike previous diagnostic tools that used to involve intravenous dye injections and exposure to a fairly bright light for 10-20 minutes, an OCTA scan can be completed within a few seconds and does not require the use of an intravenous dye. 

Dr. David Maberley is head of the VGH Eye Care Centre and a professor in the Department of Ophthalmology at the University of British Columbia.

“There are considerable challenges in providing regular retinopathy screening to all people living with diabetes in Canada,” says Maberley. “A new approach that can predict who will or will not develop vision loss will ultimately prevent visual disability and blindness.” 

The results of Karst and Maberley’s study could establish a framework for using OCTA to diagnose patients at high-risk of developing sight-threatening DR. With this greater understanding of the disease, patients at low-risk of developing severe DR could be spared frequent and time-consuming eye exams, freeing up clinical time for patients who are at a higher risk of developing sight-threatening complications.

OCTA images display the intricate network of healthy blood vessels found in the eye of a patient without DR (on the left) and the damaged capillary network in the eye of a patient with advanced DR.

“Early detection of DR can save eyesight,” says Karst. “This research will help us better understand how the disease progresses over time so that we can prevent it from doing long-lasting damage to patients’ eyesight and quality of life.”


The clinical trial is recruiting participants between the ages of 18 and 90. For more details and to learn if you qualify, contact Sonja Karst at 604-875-5475 sonja.karst@ubc.ca or Theresa Wiens at 604-875-4111 ext. 62544 twiens@eyecarecentre.org. 

Funding for this study is provided by Diabetes Action Canada, a Strategic Patient Oriented Research (SPOR) Network in Chronic Disease that is part of the Canadian Institutes of Health Research (CIHR).

 

Researchers

David Maberley

Related Articles

Behind the lab doors: Eye Care Centre

Novel AI model explains retinal sex difference

Transformative treatment for wet, age-related macular degeneration

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy